Editor-in-Chief
Hatice Kübra Elçioğlu
Vice Editors
Levent Kabasakal
Esra Tatar
Online ISSN
2630-6344
Publisher
Marmara University
Frequency
Bimonthly (Six issues / year)
Abbreviation
J.Res.Pharm.
Former Name
Marmara Pharmaceutical Journal
Journal of Research in Pharmacy
2023 , Vol 27 , Issue 3
Development and Validation of a Novel Bioanalytical Method for Estimating Epigallocatechin 3 Gallate in Wistar Rat Plasma by RP-HPLC Employing Gradient Elution Techniques
1Bharati Vidyapeeth College of Pharmacy, Kolhapur, Shivaji University, Kolhapur, Maharashtra, India2Sant Gajanan Maharaj College of Pharmacy, Mahagaon, Shivaji University, Kolhapur, Maharashtra, India
3Sharadchandra Pawar College of Pharmacy, Otur, Savitribai Phule Pune University, Pune, Maharashtra, India DOI : 10.29228/jrp.397 The goal of this study was to provide a new, easy, accurate, cost-effective, exact, sensitive, specific, robust, and rugged method for quantifying Epigallocatechin 3 gallate in wistar rat plasma using reverse phase high-performance chromatography (RP-HPLC). The stationary phase was a Zorbax SB C18 5μ (4.6*150) mm column, while the mobile phase was water with 0.1 percent formic acid (A) and acetonitrile (ACN) with 0.08 percent formic acid (B). The experiment was conducted at 30°C with a flow rate of 1.0 ml/min with PDA detectors at 274 nm. With an r2 of 0.9999, the method was shown to be linear in the concentration range of 0.2–25 μg/ml. At the same retention time (Rt) of epigallocatechin 3 gallate, no interference of co-eluting peaks of endogenous chemicals from the biological matrix was found. The intraday and interday precision RSD (%) was found to be within acceptable limits (less than 2%). The overall mean recovery percentage was determined to be 96.92 %. The LOD and LOQ were determined to be 0.0682 ± 0.0011 μg/ml and 0.205 ± 0.004 μg/ml, respectively. In short-term and long-term stability tests, auto sampler, bench-top, and freeze-thaw stability tests were found to be stable. The developed approach reported was determined to be well within acceptable limits. As a result, in the future, this method can be successfully employed in clinical laboratories to estimate epigallocatechin 3 gallate alone or in conjunction with other analytes or markers in pharmacokinetic, bioequivalence, and therapeutic drug monitoring. Keywords : Epigallocatechin 3 gallate; Wistar rat plasma; RP-HPLC; gradient elution; bioanalytical method; validation